Joseph P. Slattery

Insider Reports History

Identity 1 fact
Location
Morrisville, NC
SEC filing record 1 fact
SEC signature
/s/ Shawn Glidden, attorney-in-fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joseph P. Slattery

Form 4 holding Director

CVRx, Inc.

Security class
Common Stock
Shares / value
30,645
Estimated value
$248,225
Report date
15 Aug 2024
Price
$8.10
Ownership
Direct
Form 4 holding Director

CVRx, Inc.

Security class
Stock Option (right to buy)
Shares / value
19,554
Estimated value
$140,092
Report date
03 Jun 2025
Price
$5.14
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Morphic Holding, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
16 Aug 2024
Price
$55.79
Ownership
Direct
Form 4 holding Director

Replimune Group, Inc.

Security class
Stock Option (right to buy)
Shares / value
44,500
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ImageneBio, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
31,200
Estimated value
Report date
18 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Morphic Holding, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
16 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Joseph P. Slattery

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .